Previous close | 30.68 |
Open | 31.24 |
Bid | 31.34 x 10000 |
Ask | 32.56 x 10000 |
Day's range | 31.24 - 31.32 |
52-week range | 10.24 - 38.52 |
Volume | |
Avg. volume | 30 |
Market cap | 1.878B |
Beta (5Y monthly) | 1.64 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
SOUTH SAN FRANCISCO, Calif., March 05, 2024--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced European Union (EU) in vitro diagnostic regulations (IVDR) compliant Twist Precision Dx next-generation sequencing (NGS) Products.
SOUTH SAN FRANCISCO, Calif., February 22, 2024--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that its executives will participate in fireside chats at the following upcoming investor conferences:
SOUTH SAN FRANCISCO, Calif., February 07, 2024--As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ: TWST) ("Twist" or the "Company"), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it has granted a total of 122,400 restricted stock units ("RSUs") to 36 recently hired individuals as an inducement material to their acceptance of employment with Twist. The employment i